Pacific Biosciences Of California (PACB) Income from Non-Controlling Interests (2012 - 2015)
Pacific Biosciences Of California's (PACB) quarterly Income from Non-Controlling Interests came in at -$6000.0 in Q3 2015, up 68.42% year-on-year from -$3562.5 in Q3 2014, and down 50.0% quarter-over-quarter from -$4000.0 in Q2 2015.
Pacific Biosciences Of California (PACB) Income from Non-Controlling Interests (2012 - 2015) Analysis & Trends
Pacific Biosciences Of California's Income from Non-Controlling Interests history runs 4 years deep, the most recent figure standing at -$6000.0 for Q3 2015.
- On a quarterly basis, Income from Non-Controlling Interests rose 68.42% year-over-year to -$6000.0 in Q3 2015; TTM through Sep 2015 was -$17000.0, a 241.67% decrease from a year earlier, with the FY2014 full-year figure at -$5000.0, up 68.75% from the prior year.
- Income from Non-Controlling Interests declined to -$6000.0 in Q3 2015 per PACB's latest filing, from -$4000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $24000.0 in Q2 2014 and bottomed at -$60000.0 in Q2 2012.
- The 4-year median for Income from Non-Controlling Interests is -$7500.0 (2012), against an average of -$9214.3.
- Biggest YoY gain for Income from Non-Controlling Interests was 284.62% in 2014; the steepest drop was 566.67% in 2014.
- Year by year, Income from Non-Controlling Interests stood at -$36000.0 in 2012, then surged by 108.33% to $3000.0 in 2013, then tumbled by 566.67% to -$14000.0 in 2014, then surged by 57.14% to -$6000.0 in 2015.
- Per Business Quant, the three latest PACB Income from Non-Controlling Interests figures stand at -$6000.0 (Q3 2015), -$4000.0 (Q2 2015), and $7000.0 (Q1 2015).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.68 Bn | 99.46 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.26 Bn | 44.58 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.39 Bn | 27.28 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.22 Bn | 25.93 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Pacific Biosciences Of California | 415.91 Mn | 139.95 Mn | 12.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | -6,000.00 |
| Jun 30, 2015 | -4,000.00 |
| Mar 31, 2015 | 7,000.00 |
| Dec 31, 2014 | -14,000.00 |
| Sep 30, 2014 | -19,000.00 |
| Jun 30, 2014 | 24,000.00 |
| Mar 31, 2014 | 4,000.00 |
| Dec 31, 2013 | 3,000.00 |
| Sep 30, 2013 | 13,000.00 |
| Jun 30, 2013 | -13,000.00 |
| Mar 31, 2013 | -19,000.00 |
| Dec 31, 2012 | -36,000.00 |
| Sep 30, 2012 | -9,000.00 |
| Jun 30, 2012 | -60,000.00 |